Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4711 to 4725 of 7691 results

  1. For which service users who are moderately and severely dependent on alcohol is an assertive community treatment model a clinically and cost-effective intervention compared with standard care?

    Recommendation ID CG115/4 Question For which service users who are moderately and severely dependent on alcohol is an assertive community

  2. Frequency of monitoring:- How frequently should children be measured to identify faltering growth?

    Recommendation ID NG75/4 Question Frequency of monitoring:- How frequently should children be measured to identify faltering growth?

  3. FRAX and QFracture in adults living in residential care:- What is the utility of FRAX and QFracture in detecting risk of fragility fracture in adults living in residential care?

    Recommendation ID CG146/5 Question FRAX and QFracture in adults living in residential care:- What is the utility of FRAX and QFracture

  4. Cystourethrogram: How accurate is the first CT scan with contrast (trauma scan) for detecting bladder injuries in people with suspected bladder injuries after a traumatic incident?

    Recommendation ID NG37/02 Question Cystourethrogram: How accurate is the first CT scan with contrast (trauma scan) for detecting bladder

  5. How can a multiagency approach to improving awareness, availability and uptake of vitamin D supplements best be established, improved and sustained?

    Recommendation ID PH56/3 Question How can a multiagency approach to improving awareness, availability and uptake of vitamin D supplements

  6. How can brief advice be tailored to have the greatest impact on specific groups? For example, can it be tailored to meet the needs of people of a particular gender, socioeconomic status or with a particular disability?

    Recommendation ID PH44/5 Question How can brief advice be tailored to have the greatest impact on specific groups? For example, can it

  7. How can case-finding for hepatitis B and C be improved? What modifiable factors influence whether or not specific groups at increased risk of hepatitis B and hepatitis C infection are identified and tested?

    Recommendation ID PH43/1 Question How can case-finding for hepatitis B and C be improved? What modifiable factors influence whether or

  8. Stop-smoking interventions for under-served groups: How can effective and cost-effective interventions to support people to stop smoking be modified to improve engagement with and accessibility for under-served groups? How acceptable are these interventions to these groups?

    Recommendation ID NG209/03 Question Stop-smoking interventions for under-served groups: How can effective and cost-effective interventions

  9. How can fetuses at risk of intrauterine death be identified in women with diabetes?

    Recommendation ID NG3/4 Question How can fetuses at risk of intrauterine death be identified in women with diabetes? Any explanatory

  10. How can interventions which have been proven effective in other countries be assessed for their cultural relevance to the UK? What measures should be used to assess how transferrable they are?

    Recommendation ID PH40/5 Question How can interventions which have been proven effective in other countries be assessed for their cultural

  11. Frequency of monitoring:- What is the effectiveness of more frequent monitoring compared with monitoring at 12 months after diagnosis in people with newly diagnosed coeliac disease?

    Recommendation ID NG20/5 Question Frequency of monitoring:- What is the effectiveness of more frequent monitoring compared with monitoring

  12. Frequency of monitoring:- What is the long-term cost effectiveness, in terms of patient-relevant outcomes including bestcorrected visual acuity and quality of life, of different review frequencies/strategies for people at risk of progression to late AMD (wet active)?

    Recommendation ID NG82/4 Question Frequency of monitoring:- What is the long-term cost effectiveness, in terms of patient-relevant outcomes